EFFIPURE
DEAD

Serial Number

78246754

Owner

Exact Sciences Corporation

Attorney

Douglas R. Wolf

Filing Date

May 7, 2003

Add to watchlist:

No watchlists yet
View on USPTO

EFFIPURE Trademark

Serial Number: 78246754

EFFIPURE is a trademark filed by Exact Sciences Corporation on May 7, 2003. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Exact Sciences Corporation (126 trademarks)

441 Charmany Drive
Madison, WI 53719

Entity Type: 03

Trademark Details

Filing Date

May 7, 2003

Registration Date

Not Registered

Goods & Services

Gel cassettes for use in clinical and medical applications used in the field of medicine with a base, safety cover, comb, electrode and electrical power supply; and optical scanners and computer software for use in clinical and medical applications in the field of medicine

Gel cassettes for use in clinical and medical applications used in the field of medicine without a base, safety cover, comb, electrode and electrical power supply; Micro array reagents for use in clinical and medical applications used in the field of medicine; Reagents, namely micro arrays for clinical medical use; Reagents, namely gel cassettes for clinical or medical use in electrophoresis assays; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting analysts; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in purifying analytes analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in separating analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting nucleic acid sequences; Reagents for clinical medical diagnostic electrophoresis assays, namely gel cassettes for use in purifying nucleic acid secluences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in separating nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting bacterial contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting viral contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting bacterial contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in identifying bacterial pathogens; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect analytes; Reagent kits for clinical medical use, namely kits comprised of micro arrays and reagents; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to purify analytes;Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to separate analytes; Reagent kits for clinical medical use, namely kits comprised of gel cassettes and reagents use to detect nucleic acid sequences; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to purify nucleic acid sequences; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to separate nucleic acid sequences; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect contamination in blood products; Reagent kits for clinical medical use in diagnostic electrcphoresms assays, namely kits comprised of gel cassettes and reagents used to detect bacterial contamination in blood products; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect viral contamination in blood products; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect contamination in platelet products; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect bacterial contamination in platelet products; and Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to identify bacterial pathogens

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 30, 2005 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 30, 2005 ABN2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2005 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2005 REAP
NON-FINAL ACTION MAILED
Jun 3, 2005 CNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2005 CNRT
AMENDMENT FROM APPLICANT ENTERED
Mar 18, 2005 ACEC
ASSIGNED TO LIE
Mar 18, 2005 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2005 CRFA
PAPER RECEIVED
Feb 4, 2005 MAIL
ASSIGNED TO EXAMINER
Jan 2, 2005 DOCK
FAX SENT
Nov 2, 2004 FAXX
NON-FINAL ACTION MAILED
Aug 11, 2004 CNRT
ASSIGNED TO EXAMINER
Aug 10, 2004 DOCK
FINAL REFUSAL MAILED
May 5, 2004 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2004 CRFA
PAPER RECEIVED
Apr 2, 2004 MAIL
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Nov 17, 2003 UNPR
PAPER RECEIVED
Nov 17, 2003 MAIL
NON-FINAL ACTION MAILED
Oct 10, 2003 CNRT
ASSIGNED TO EXAMINER
Oct 7, 2003 DOCK
PAPER RECEIVED
Aug 6, 2003 MAIL